Bloomberg Markets & Finance via Youtube


Nov.16 — Moderna Inc. said its Covid-19 vaccine was 94.5% effective in a preliminary analysis of a large late-stage clinical trial, another sign that a fast-paced hunt by scientists and pharmaceutical companies is paying off with potent new tools that could help control a worsening pandemic. Sam Fazeli of Bloomberg Intelligence has the details on “Bloomberg Surveillance.”

READ ALSO  SE: Amazon Unions in Europe Plan Black Friday Protests